Stuart J Blincko

Title: The Innovations of Stuart J Blincko

Introduction

Stuart J Blincko is a notable inventor based in Sussex, GB. He has made significant contributions to the field of immunology, particularly in the development of immunogenic compositions. His work focuses on creating solutions for medical challenges, specifically related to tricyclic antidepressant drugs.

Latest Patents

Stuart J Blincko holds 1 patent for an immunogenic composition against tricyclic antidepressant drugs. This innovative composition is designed to raise antisera to a drug by utilizing an immunologically active carrier protein. The composition includes at least two types of hapten, each comprising a drug molecule, and optionally, a bridging group. Additionally, he has developed methods for raising antisera to a drug using this immunogenic composition, as well as a method for alleviating an overdose of a tricyclic depressant drug through the administration of an effective amount of antisera raised to the immunogen.

Career Highlights

Throughout his career, Stuart has worked with prominent companies in the pharmaceutical industry. He has been associated with Therapeutic Antibodies, Inc. and Abbott Laboratories Corporation, where he has contributed to various projects and advancements in drug development.

Collaborations

Stuart has collaborated with several professionals in his field, including Deborah A Blackwell and Emma J Doran. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in immunology.

Conclusion

Stuart J Blincko's work exemplifies the impact of innovation in the medical field, particularly in addressing challenges related to antidepressant drugs. His contributions through patents and collaborations highlight the importance of research in developing effective medical solutions.